125 related articles for article (PubMed ID: 26745067)
21. Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference.
Jiang M; Milner J
Oncogene; 2002 Sep; 21(39):6041-8. PubMed ID: 12203116
[TBL] [Abstract][Full Text] [Related]
22. Induction of cell death in human papillomavirus 18-positive cervical cancer cells by E6 siRNA.
Yamato K; Fen J; Kobuchi H; Nasu Y; Yamada T; Nishihara T; Ikeda Y; Kizaki M; Yoshinouchi M
Cancer Gene Ther; 2006 Mar; 13(3):234-41. PubMed ID: 16138119
[TBL] [Abstract][Full Text] [Related]
23. A single-codon mutation converts HPV16 E6 oncoprotein into a potential tumor suppressor, which induces p53-dependent senescence of HPV-positive HeLa cervical cancer cells.
Ristriani T; Fournane S; Orfanoudakis G; Travé G; Masson M
Oncogene; 2009 Feb; 28(5):762-72. PubMed ID: 19015633
[TBL] [Abstract][Full Text] [Related]
24. Activities of E6 Protein of Human Papillomavirus 16 Asian Variant on miR-21 Up-regulation and Expression of Human Immune Response Genes.
Chopjitt P; Pientong C; Bumrungthai S; Kongyingyoes B; Ekalaksananan T
Asian Pac J Cancer Prev; 2015; 16(9):3961-8. PubMed ID: 25987069
[TBL] [Abstract][Full Text] [Related]
25. Analysis of p53 codon 72 polymorphism and its association with human papillomavirus 16 and 18 E6 in Chinese cervical lesions.
Min-min H; Ming-rong X; Ze-yi C; Kai-xuan Y; Zhi-lin S
Int J Gynecol Cancer; 2006; 16(6):2004-8. PubMed ID: 17177838
[TBL] [Abstract][Full Text] [Related]
26. Adenovirus-mediated transfer of human papillomavirus 16 E6/E7 antisense RNA and induction of apoptosis in cervical cancer.
Hamada K; Shirakawa T; Gotoh A; Roth JA; Follen M
Gynecol Oncol; 2006 Dec; 103(3):820-30. PubMed ID: 16908054
[TBL] [Abstract][Full Text] [Related]
27. [Relationship between nitric oxide in cervical microenvironment and different HPV types and effect on cervical cancer cells].
Wei XM; Wang Q; Gao SJ; Sui L
Zhonghua Fu Chan Ke Za Zhi; 2011 Apr; 46(4):260-5. PubMed ID: 21609578
[TBL] [Abstract][Full Text] [Related]
28. Antiproliferative effects of AAV-delivered CRISPR/Cas9-based degradation of the HPV18-E6 gene in HeLa cells.
Noroozi Z; Shamsara M; Valipour E; Esfandyari S; Ehghaghi A; Monfaredan A; Azizi Z; Motevaseli E; Modarressi MH
Sci Rep; 2022 Feb; 12(1):2224. PubMed ID: 35140292
[TBL] [Abstract][Full Text] [Related]
29. [Antisense targeting to human papillomavirus 18 E6/E7 affects the proliferation and apoptosis of human cervical carcinoma: an in vitro experiment with HeLa cells].
Sima N; Kong DB; Wang W; Lu YP; Wang SX; Ma D
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(23):1618-21. PubMed ID: 17803852
[TBL] [Abstract][Full Text] [Related]
30. Adenovirus-mediated transfer of HPV 16 E6/E7 antisense RNA to human cervical cancer cells.
Hamada K; Sakaue M; Alemany R; Zhang WW; Horio Y; Roth JA; Mitchell MF
Gynecol Oncol; 1996 Nov; 63(2):219-27. PubMed ID: 8910631
[TBL] [Abstract][Full Text] [Related]
31. Association of p53 codon 72 genotypes and clinical outcome in human papillomavirus-infected lung cancer patients.
Chen SP; Hsu NY; Wu JY; Chen CY; Chou MC; Lee H; Cheng YW
Ann Thorac Surg; 2013 Apr; 95(4):1196-203. PubMed ID: 23522190
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of cervical cancer cell growth in vitro and in vivo with lentiviral-vector delivered short hairpin RNA targeting human papillomavirus E6 and E7 oncogenes.
Gu W; Putral L; Hengst K; Minto K; Saunders NA; Leggatt G; McMillan NA
Cancer Gene Ther; 2006 Nov; 13(11):1023-32. PubMed ID: 16810314
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of growth of cervical cancer cells using a dominant negative estrogen receptor gene.
Au WW; Abdou-Salama S; Al-Hendy A
Gynecol Oncol; 2007 Feb; 104(2):276-80. PubMed ID: 17137618
[TBL] [Abstract][Full Text] [Related]
34. Anti-cancer effect of adenovirus p53 on human cervical cancer cell growth in vitro and in vivo.
Ahn WS; Bae SM; Lee JM; Namkoong SE; Yoo JY; Seo YS; Nam SL; Cho YL; Nam KH; Kim CK; Kim YW
Int J Gynecol Cancer; 2004; 14(2):322-32. PubMed ID: 15086733
[TBL] [Abstract][Full Text] [Related]
35. Specific apoptosis induction in human papillomavirus-positive cervical carcinoma cells by photodynamic antisense regulation.
Yamayoshi A; Kato K; Suga S; Ichinoe A; Arima T; Matsuda T; Kato H; Murakami A; Wake N
Oligonucleotides; 2007; 17(1):66-79. PubMed ID: 17461764
[TBL] [Abstract][Full Text] [Related]
36. Activation of p53 in cervical cancer cells by human papillomavirus E6 RNA interference is transient, but can be sustained by inhibiting endogenous nuclear export-dependent p53 antagonists.
Koivusalo R; Mialon A; Pitkänen H; Westermarck J; Hietanen S
Cancer Res; 2006 Dec; 66(24):11817-24. PubMed ID: 17178878
[TBL] [Abstract][Full Text] [Related]
37. Pitx2a binds to human papillomavirus type 18 E6 protein and inhibits E6-mediated P53 degradation in HeLa cells.
Wei Q
J Biol Chem; 2005 Nov; 280(45):37790-7. PubMed ID: 16129685
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of Bax activity is crucial for the antiapoptotic function of the human papillomavirus E6 oncoprotein.
Vogt M; Butz K; Dymalla S; Semzow J; Hoppe-Seyler F
Oncogene; 2006 Jul; 25(29):4009-15. PubMed ID: 16462759
[TBL] [Abstract][Full Text] [Related]
39. Star-PAP controls HPV E6 regulation of p53 and sensitizes cells to VP-16.
Li W; Anderson RA
Oncogene; 2014 Feb; 33(7):928-32. PubMed ID: 23416977
[TBL] [Abstract][Full Text] [Related]
40. Gene silencing with siRNA targeting E6/E7 as a therapeutic intervention in a mouse model of cervical cancer.
Jonson AL; Rogers LM; Ramakrishnan S; Downs LS
Gynecol Oncol; 2008 Nov; 111(2):356-64. PubMed ID: 18755502
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
